-
-
-
-
-
-
-
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
-
-
-
-
-
-
-
Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
-
-
-
-
-
-
-
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
-
-
-
-
-
-
-
Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
-
-
-
-
-
-
-
Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
-
-
-
-
-
-
-
Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
-
-
-
-
-
-
-
Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

